secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2022-12-15T23:59:59+00:00
Accession:  0001493152-22-035628
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 5.07, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix shareholders approve reverse stock split (1-for-2 to 1-for-50) and equity plan increase
--------------------------------------------------------------------------------

- Reverse stock split approved at ratio range of 1-for-2 to 1-for-50, effective at Board's discretion within 6 months.
- 2014 Long-Term Incentive Plan shares increased by 1,518,000 to total 4,864,286 shares.
- All eight director nominees elected: Cassirer, Fashek, Ferguson, Goldstein, Jacob, Mika, Murphy, Schroeder.
- Proposals to classify the Board and increase authorized common shares from 40M to 45M failed.
- Marcum LLP ratified as independent auditor for fiscal year 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315222035628/0001493152-22-035628-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315222035628/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-035628

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer